Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Associate Scientist

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Jan 27, 2021

View more

Discipline
Science/R&D, Biotechnology
Required Education
Masters Degree/MBA
Position Type
Full time
Hotbed
Genetown

Job Details

Our Mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Job Description:

RESPONSIBILITIES:

Design, implement, and troubleshoot experiments independently. Collaborate with colleagues to reach desired goals. Establish and perform in vitro assays to support natural killer cell related projects, including immune cell isolation, intracellular flow cytometry staining, multicolor flow cytometry, cytokine profiling assay, CFSE proliferation assay, and mixed lymphocyte reaction (MLR) assay. Use technical and literature knowledge to analyze and interpret results. Contribute to scientific strategy of a project from theoretical knowledge and adapts experimental workflow. Troubleshoot technical issues and expands the technical capabilities of group. Communicate research and development findings with internal and external teams in a clear and concise manner. Mentor junior team member(s) and servers as a role model.

QUALIFICATIONS:

Requires a Master's degree in Biotechnology, Immunology, or a directly related field plus four (4) years of industrial experience.

Must have three (3) years of experience with the following (experience may be gained concurrently):
  • Knowledge of T cell biology, alloimmunity, engineered T cells (CAR-T and TCR-T), or NK biology
  • Hands-on experience with immunology assays, including immune cell isolation, intracellular flow cytometry, multicolor flow cytometry, and immune cell profiling
  • Hands-on experience with cytokine profiling assay by ELISA or MSD
  • Hands-on experience in assay development, troubleshooting and target validation


Must have one (1) year of experience with the following (experience may be gained concurrently):
  • Hands-on experience with gene editing by CRISPR in T cells or other immune cells


Telecommuting : Position is fixed location based in the Cambridge, MA office; However, telecommuting is occasionally allowed from home office location.

40 hours per week. Day shift. Send resume to: Deepanker.Goyal@intelliatx.com ref. P20.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert